Office intrauterine morcellation for retained products of conception

Abstract

Objective

Proposing hysteroscopic morcellation (HM) as a surgical-therapeutic approach in the treatment of retained products of conception (RPOC) to prevent intrauterine adhesions (IUAs).

Design

Prospective analysis.

Setting

A teaching and university hospital.

Patients

Women with RPOC.

Interventions

Office -HM with ‘Truclear 5 C’.

Material and methods

Twenty-two consecutive patients presenting with trophoblastic residue retention after miscarriage and interruption of pregnancy or placenta remnants after cesarean section or delivery were enrolled. These women underwent office-HM with ‘Truclear 5 C’. Primary outcomes were median time and rate of hospitalization. The quality of the specimen was also analyzed. A hysteroscopic second look for IUAs was performed.

Results

Mean procedure time was six minutes (SD ± 5). Tissue samples had a mean collection size 2.5 cm³+0.9. 38% of the samples had spotting or abnormal vaginal discharge. Dilatation of the cervical canal was not performed in any case. Second-look hysteroscopy did not show any de novo IUAs in any of the enrolled patients.

Conclusions

In the hysteroscopic treatment of RPOC, HM is a valid choice in an office setting without the use of cervical dilatation. Removal of RPOC was uneventful in all cases, simple and carried out faster without any adverse outcomes.

Keywords:

• Hysteroscopic morcellator
• myosure
• truclear
• placenta residues
• placenta remnants
• trophoblastic residues
• placenta lesions
• retained products of conception

Disclosure statement

No potential conflict of interest was reported by the author(s).